Financials Resonance Health Limited

Equities

RHT

AU000000RHT2

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 08:06:49 2024-04-25 pm EDT 5-day change 1st Jan Change
0.085 AUD 0.00% Intraday chart for Resonance Health Limited +4.94% +41.67%

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 9.66 44.36 66.57 71.48 25.82 19.37
Enterprise Value (EV) 1 8.111 41.28 59.71 62.68 19.31 13.28
P/E ratio 43 x 33.9 x -88.2 x 119 x -22.4 x -24.7 x
Yield - - - - - -
Capitalization / Revenue 3.34 x 12.2 x 18.1 x 18.9 x 6.7 x 4.33 x
EV / Revenue 2.8 x 11.4 x 16.3 x 16.6 x 5.01 x 2.97 x
EV / EBITDA -72.4 x 39.5 x -63.2 x 144 x -13 x -10.1 x
EV / FCF -14 x 63 x 51 x 172 x -10.9 x -30.1 x
FCF Yield -7.13% 1.59% 1.96% 0.58% -9.21% -3.32%
Price to Book 2.34 x 7.53 x 6.72 x 6.04 x 2.42 x 1.95 x
Nbr of stocks (in thousands) 402,498 422,498 443,774 461,150 461,150 461,150
Reference price 2 0.0240 0.1050 0.1500 0.1550 0.0560 0.0420
Announcement Date 9/13/18 9/27/19 9/30/20 9/29/21 9/29/22 8/29/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net sales 1 2.896 3.625 3.668 3.779 3.853 4.471
EBITDA 1 -0.112 1.045 -0.9446 0.4364 -1.491 -1.32
EBIT 1 -0.1389 1.021 -0.964 0.4173 -1.525 -1.36
Operating Margin -4.8% 28.18% -26.28% 11.04% -39.57% -30.42%
Earnings before Tax (EBT) 1 -0.2273 0.9417 -0.9527 0.3435 -1.552 -1.264
Net income 1 0.2246 1.27 -0.7151 0.5859 -1.142 -0.7804
Net margin 7.76% 35.05% -19.49% 15.5% -29.63% -17.45%
EPS 2 0.000558 0.003099 -0.001700 0.001299 -0.002499 -0.001699
Free Cash Flow 1 -0.5787 0.6549 1.17 0.3635 -1.778 -0.4409
FCF margin -19.98% 18.07% 31.9% 9.62% -46.14% -9.86%
FCF Conversion (EBITDA) - 62.66% - 83.31% - -
FCF Conversion (Net income) - 51.56% - 62.05% - -
Dividend per Share - - - - - -
Announcement Date 9/13/18 9/27/19 9/30/20 9/29/21 9/29/22 8/29/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1.55 3.08 6.86 8.8 6.51 6.09
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.58 0.65 1.17 0.36 -1.78 -0.44
ROE (net income / shareholders' equity) 5.71% 25.3% -9.05% 5.39% -10.1% -7.57%
ROA (Net income/ Total Assets) -1.87% 11.5% -7.12% 2.27% -7.9% -7.5%
Assets 1 -12.04 11.05 10.04 25.76 14.45 10.4
Book Value Per Share 2 0.0100 0.0100 0.0200 0.0300 0.0200 0.0200
Cash Flow per Share 2 0 0.0100 0.0200 0.0200 0.0100 0.0100
Capex 1 0.01 0 0 0.04 0.12 0.29
Capex / Sales 0.51% 0.09% 0.06% 1.17% 3.09% 6.45%
Announcement Date 9/13/18 9/27/19 9/30/20 9/29/21 9/29/22 8/29/23
1AUD in Million2AUD
Estimates
  1. Stock Market
  2. Equities
  3. RHT Stock
  4. Financials Resonance Health Limited